← Back to all trials
Active Not Recruiting
NCT02301767
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study
Conditions: Breast Cancer
Sex: Female
Ages: 21 Years – 69 Years
Healthy volunteers: No
Enrollment: 2187
Sponsor: Memorial Sloan Kettering Cancer Center
Location: Memorial Sloan Kettering Cancer Center Basking Ridge New Jersey
Summary
The purpose of the study is to view what normal breast tissue looks like on an MRI and mammogram to help determine how it may affect the risk of developing breast cancer. The investigators will also compare the information collected from the questionnaire and medical records to help better understand how this may affect the risk of developing breast cancer. If a saliva or tissue sample is collected for future use, this information will enable us to study genetic risk factors as well.
Eligibility Criteria
Inclusion Criteria:
* Eligibility Criteria for Breast Cancer Cases (invasive)
Women with the following characteristics at MRI will be eligible as invasive cases:
1. have a diagnosed invasive unilateral breast cancer after 1/1/2010;
2. have a pre-treatment (prior to bilateral mastectomy, radiation, hormonal, and/or chemotherapy) bilateral breast MRI with contrast available from the study site;
3. be ≥ 21 and \
Source: ClinicalTrials.gov (NCT02301767). StuddyBuddy aggregates publicly available trial information.
